Pharma Focus Europe

Astorg Completes Acquisition of OPEN Health From Amulet Capital Partners

Tuesday, July 19, 2022

Astorg and Amulet Capital Partners have finalized the acquisition of OPEN Health, a global provider of scientific communications and market access services to the pharmaceutical industry. OPEN Health, established in 2011, operates in 15 locations across six countries with over 1,000 employees. The company offers scientific communications, health economics and outcomes research (HEOR), and market access services to more than 170 life sciences clients. The existing management team of OPEN Health will continue leading the organization, leveraging their expertise and track record of organic growth and strategic acquisitions.

Rob Barker, CEO of OPEN Health, expressed gratitude for the support and partnership provided by Amulet over the past years. He looks forward to collaborating with the Astorg team to expand the company's capabilities and deliver exceptional scientific communication services to customers.

Judith Charpentier, Partner and Head of Healthcare at Astorg, welcomed OPEN Health to the Astorg family and emphasized the goal of building a global leader in the medical affairs and market access domain. She acknowledged the increasing significance of OPEN Health's expertise in the pharmaceutical industry and highlighted opportunities to support the company's diverse and expanding customer base.

Ramsey Frank, President and Managing Partner of Amulet, highlighted the comprehensive value creation approach of the investment in OPEN Health. Amulet aims to partner with exceptional management teams to develop industry-leading businesses in attractive healthcare subsectors. Frank expressed confidence in OPEN Health's future growth and success in collaboration with Astorg.

Overall, the completion of this transaction marks a significant milestone for OPEN Health and sets the stage for further expansion and success in the field of scientific communications and market access services.

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva